(Q41245724)

28 September 2017

1 reference

title

Characteristics of materials distributed by drug companies. An evaluation of appropriateness (English)

1 reference

28 September 2017

D Stryer

1

1 reference

PubMed ID

8945688

28 September 2017

L A Bero

series ordinal

2

1 reference

28 September 2017

1 October 1996

1 reference

Journal of General Internal Medicine

28 September 2017

1 reference

28 September 2017

11

1 reference

28 September 2017

10

1 reference

28 September 2017

575-583

1 reference

https://scigraph.springernature.com/pub.10.1007/bf02599024

28 September 2017

0 references

cites work

Analysis of the bureaucratic unsolicited mountainous paper heap (BUMPH) that general practitioners received in 1994.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02599024

The weight-based heparin dosing nomogram compared with a "standard care" nomogram. A randomized controlled trial

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02599024

Therapeutic-class wars--drug promotion in a competitive marketplace

21 January 2018

1 reference

12 December 2020

Pharmaceutical Promotions — A Free Lunch?

1 reference

12 December 2020

The accuracy of drug information from pharmaceutical sales representatives

1 reference

12 December 2020

1 reference

12 December 2020

Keeping prescription drug advertising honest. FDA's watchful eye.

1 reference

12 December 2020

A comparison of real-time compression ultrasonography with impedance plethysmography for the diagnosis of deep-vein thrombosis in symptomatic outpatients

1 reference

12 December 2020

The FDA and drug marketing expenditures

1 reference

12 December 2020

Education or promotion?

1 reference

12 December 2020

The federal regulation of prescription drug advertising and promotion

1 reference

12 December 2020

Impact of a drug bulletin on the knowledge, perception of drug utility, and prescribing behavior of physicians

1 reference

12 December 2020

Pertussis immunisation and serious acute neurological illnesses in children

1 reference

12 December 2020

Doctors and detailers: therapeutic education or pharmaceutical promotion?

1 reference

12 December 2020

Treatment of active Crohn's disease by exclusion diet: East Anglian multicentre controlled trial

1 reference

12 December 2020

Treatment of rheumatoid arthritis with gammalinolenic acid

1 reference

12 December 2020

Interactions between a general practitioner and representatives of drug companies

1 reference

12 December 2020

An economic evaluation of screening for Chlamydia trachomatis in adolescent males

1 reference

12 December 2020

Policies regulating the activities of pharmaceutical representatives in residency programs

1 reference

12 December 2020

The regulation of prescription drug advertising

1 reference

12 December 2020

Doctors, drug companies, and gifts

1 reference

12 December 2020

Who really determines your patients' prescriptions?

1 reference

12 December 2020

The effects of pharmaceutical firm enticements on physician prescribing patterns. There's no such thing as a free lunch.

1 reference

12 December 2020

Pharmaceutical ads in journals

1 reference

12 December 2020

Evaluation of urine-based screening strategies to detect Chlamydia trachomatis among sexually active asymptomatic young males

1 reference

12 December 2020

Novel gifts from pharmaceutical companies

1 reference

12 December 2020

Of mugs and marketing

1 reference

12 December 2020

A comparison of subcutaneous low-molecular-weight heparin with warfarin sodium for prophylaxis against deep-vein thrombosis after hip or knee implantation

1 reference

12 December 2020

Changes in physicians' sources of pharmaceutical information: a review and analysis

1 reference

12 December 2020

Physicians' behavior and their interactions with drug companies. A controlled study of physicians who requested additions to a hospital drug formulary

1 reference

12 December 2020

The relationship between physicians and the pharmaceutical industry. A report of the Royal College of Physicians

1 reference

12 December 2020

Training the resident to meet the detail men

1 reference

12 December 2020

Draft policy statement on industry-supported scientific and educational activities; notice.

1 reference

12 December 2020

FDA regulation of prescription drug advertising

1 reference

12 December 2020

Gene marking to determine whether autologous marrow infusion restores long-term haemopoiesis in cancer patients

1 reference

12 December 2020

Basic information that prescribers are not getting about drugs

1 reference

12 December 2020

Scientific versus commercial sources of influence on the prescribing behavior of physicians

1 reference

12 December 2020

Gifts to physicians from industry

1 reference

12 December 2020

Drug bulletins: effectiveness in modifying prescribing and methods of improving impact

1 reference

12 December 2020

The publication of sponsored symposiums in medical journals

1 reference

12 December 2020

Drug promotion for an unlabeled indication--the case of topical tretinoin

1 reference

12 December 2020

Sponsored symposia on environmental tobacco smoke

1 reference

12 December 2020

Randomised controlled trial of oxytocin alone versus oxytocin and ergometrine in active management of third stage of labour

1 reference

12 December 2020

Teaching drug promotion abuses to health profession students

1 reference

12 December 2020

The relationship between physicians in training and pharmaceutical companies. A time for guidelines?

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02599024

1 reference

PubMed ID

8945688

Dimensions Publication ID

28 September 2017

0 references

1 reference

PubMed ID

8945688